BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ayo A, Laakkonen P. Peptide-Based Strategies for Targeted Tumor Treatment and Imaging. Pharmaceutics 2021;13:481. [PMID: 33918106 DOI: 10.3390/pharmaceutics13040481] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 20.0] [Reference Citation Analysis]
Number Citing Articles
1 Mansour S, Adhya I, Lebleu C, Dumpati R, Rehan A, Chall S, Dai J, Errasti G, Delacroix T, Chakrabarti R. Identification of a novel peptide ligand for the cancer-specific receptor mutation EGFRvIII using high-throughput sequencing of phage-selected peptides. Sci Rep 2022;12:20725. [PMID: 36456600 DOI: 10.1038/s41598-022-25257-4] [Reference Citation Analysis]
2 Cheng Z, Ma J, Yin L, Yu L, Yuan Z, Zhang B, Tian J, Du Y. Non-invasive molecular imaging for precision diagnosis of metastatic lymph nodes: opportunities from preclinical to clinical applications. Eur J Nucl Med Mol Imaging 2022. [DOI: 10.1007/s00259-022-06056-5] [Reference Citation Analysis]
3 Sokolov AV, Isakova-Sivak IN, Mezhenskaya DA, Kostevich VA, Gorbunov NP, Elizarova AY, Matyushenko VA, Berson YM, Grudinina NA, Kolmakov NN, Zabrodskaya YA, Komlev AS, Semak IV, Budevich AI, Rudenko LG, Vasilyev VB. Molecular mimicry of the receptor-binding domain of the SARS-CoV-2 spike protein: from the interaction of spike-specific antibodies with transferrin and lactoferrin to the antiviral effects of human recombinant lactoferrin. Biometals 2022. [PMID: 36334191 DOI: 10.1007/s10534-022-00458-6] [Reference Citation Analysis]
4 Sharma R, Borah SJ, Bhawna, Kumar S, Gupta A, Singh P, Goel VK, Kumar R, Kumar V. Functionalized Peptide-Based Nanoparticles for Targeted Cancer Nanotherapeutics: A State-of-the-Art Review. ACS Omega. [DOI: 10.1021/acsomega.2c03974] [Reference Citation Analysis]
5 Karami Fath M, Babakhaniyan K, Anjomrooz M, Jalalifar M, Alizadeh SD, Pourghasem Z, Abbasi Oshagh P, Azargoonjahromi A, Almasi F, Manzoor HZ, Khalesi B, Pourzardosht N, Khalili S, Payandeh Z. Recent Advances in Glioma Cancer Treatment: Conventional and Epigenetic Realms. Vaccines (Basel) 2022;10:1448. [PMID: 36146527 DOI: 10.3390/vaccines10091448] [Reference Citation Analysis]
6 Gangadaran P, Gunassekaran GR, Rajendran RL, Oh JM, Vadevoo SMP, Lee HW, Hong CM, Lee B, Lee J, Ahn B. Interleukin-4 Receptor Targeting Peptide Decorated Extracellular Vesicles as a Platform for In Vivo Drug Delivery to Thyroid Cancer. Biomedicines 2022;10:1978. [DOI: 10.3390/biomedicines10081978] [Reference Citation Analysis]
7 Bose D, Roy L, Chatterjee S. Peptide therapeutics in the management of metastatic cancers. RSC Adv 2022;12:21353-73. [PMID: 35975072 DOI: 10.1039/d2ra02062a] [Reference Citation Analysis]
8 Ranjbar V, Molavipordanjani S, Biabani Ardakani J, Akhlaghi M, Nikkholgh B, Hosseinimehr SJ. Initial preclinical evaluation of 68Ga-DOTA-(Ser)3-LTVSPWY peptide as a PET radiotracer for glioblastoma targeting and imaging. Nucl Med Commun 2022. [PMID: 35754162 DOI: 10.1097/MNM.0000000000001590] [Reference Citation Analysis]
9 Manivannan AC, Dhandapani R, Velmurugan P, Thangavelu S, Paramasivam R, Ragunathan L, Saravanan M. Phage in cancer treatment - Biology of therapeutic phage and screening of tumor targeting peptide. Expert Opin Drug Deliv 2022. [PMID: 35748094 DOI: 10.1080/17425247.2022.2094363] [Reference Citation Analysis]
10 Xue A, Fan S. Matrices and Affinity Ligands for Antibody Purification and Corresponding Applications in Radiotherapy. Biomolecules 2022;12:821. [PMID: 35740946 DOI: 10.3390/biom12060821] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Tong S, Darwish S, Ariani HHN, Lozada KA, Salehi D, Cinelli MA, Silverman RB, Kaur K, Yang S. A Small Peptide Increases Drug Delivery in Human Melanoma Cells. Pharmaceutics 2022;14:1036. [DOI: 10.3390/pharmaceutics14051036] [Reference Citation Analysis]
12 Zhang Q, Olberg A, Sioud M. Structural Requirements for the Binding of a Peptide to Prohibitins on the Cell Surface of Monocytes/Macrophages. Int J Mol Sci 2022;23:4282. [PMID: 35457098 DOI: 10.3390/ijms23084282] [Reference Citation Analysis]
13 Mathew EN, Berry BC, Yang HW, Carroll RS, Johnson MD. Delivering Therapeutics to Glioblastoma: Overcoming Biological Constraints. Int J Mol Sci 2022;23:1711. [PMID: 35163633 DOI: 10.3390/ijms23031711] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
14 Garg P. Radiobioconjugate targeted therapy in cancer, using radiolabeled mediated biological analogs: Desired qualities and selective targeting approach. Biomed Biotechnol Res J 2022;6:40. [DOI: 10.4103/bbrj.bbrj_282_21] [Reference Citation Analysis]
15 Jarak I, Pereira-silva M, Santos AC, Veiga F, Cabral H, Figueiras A. Multifunctional polymeric micelle-based nucleic acid delivery: Current advances and future perspectives. Applied Materials Today 2021;25:101217. [DOI: 10.1016/j.apmt.2021.101217] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
16 Kasprzak A. Somatostatin and Its Receptor System in Colorectal Cancer. Biomedicines 2021;9:1743. [PMID: 34829972 DOI: 10.3390/biomedicines9111743] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Chen YA, Ho CL, Ku MT, Hwu L, Lu CH, Chiu SJ, Chang WY, Liu RS. Detection of cancer stem cells by EMT-specific biomarker-based peptide ligands. Sci Rep 2021;11:22430. [PMID: 34789743 DOI: 10.1038/s41598-021-01138-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
18 Loh JS, Tan LKS, Lee WL, Ming LC, How CW, Foo JB, Kifli N, Goh BH, Ong YS. Do Lipid-based Nanoparticles Hold Promise for Advancing the Clinical Translation of Anticancer Alkaloids? Cancers (Basel) 2021;13:5346. [PMID: 34771511 DOI: 10.3390/cancers13215346] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Sanmukh SG, Santos NJ, Barquilha CN, Dos Santos SAA, Duran BOS, Delella FK, Moroz A, Justulin LA, Carvalho HF, Felisbino SL. Exposure to Bacteriophages T4 and M13 Increases Integrin Gene Expression and Impairs Migration of Human PC-3 Prostate Cancer Cells. Antibiotics (Basel) 2021;10:1202. [PMID: 34680783 DOI: 10.3390/antibiotics10101202] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Lechner VM, Nappi M, Deneny PJ, Folliet S, Chu JCK, Gaunt MJ. Visible-Light-Mediated Modification and Manipulation of Biomacromolecules. Chem Rev 2021. [PMID: 34546740 DOI: 10.1021/acs.chemrev.1c00357] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 24.0] [Reference Citation Analysis]
21 Rizvi SFA, Shahid S, Mu S, Zhang H. Hybridization of tumor homing and mitochondria-targeting peptide domains to design novel dual-imaging self-assembled peptide nanoparticles for theranostic applications. Drug Deliv Transl Res 2021. [PMID: 34535874 DOI: 10.1007/s13346-021-01066-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Rizvi SFA, Ali A, Ahmad M, Mu S, Zhang H. Multifunctional self-assembled peptide nanoparticles for multimodal imaging-guided enhanced theranostic applications against glioblastoma multiforme. Nanoscale Adv 2021;3:5959-5967. [DOI: 10.1039/d1na00597a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]